The rearrangements involving MYC (MYC-R) are a defining genetic alteration of high-grade B-cell lymphomas (HGBL) carrying BCL2 and/or BCL6 rearrangements, as well as Burkitt lymphoma (BL) [3, 4]. The gene discussed is BCL2; the disease is Burkitt lymphoma.